Ameriprise Financial Inc Assertio Holdings, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.02 - $2.57 $42,076 - $106,015	-41,251 Reduced 14.85%	236,619 $253,000
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $8,152 - $18,407	3,235 Added 1.18%	277,870 $711,000
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $66,235 - $101,472	13,247 Added 5.07%	274,635 $1.49 Million
Q1 2023 May 15, 2023	SELL	$3.54 - $6.66 $386,391 - $726,939	-109,150 Reduced 29.46%	261,388 $1.67 Million
Q4 2022 Feb 14, 2023	SELL	$2.11 - $4.3 $9,037 - $18,416	-4,283 Reduced 1.14%	370,538 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $798,368 - $1.5 Million	374,821 New	374,821 $851,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $41.9M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.